Bioventus (BVS): #1 Ranked Stock Out of 4,600

By Steve Reitmeister, Editor-in-Chief, WallStreetZen
July 24, 2026 3:32 PM UTC
Bioventus (BVS): #1 Ranked Stock Out of 4,600

Let’s start with the best part…Bioventus (BVS) is the #1 ranked stock in the entire Zen Ratings system. 

Not top 1%. 

Stock #1 (period). 

I have featured this thriving medical device company a few times on my YouTube videos including about 10 minutes into this recent video.

Plus it is one of the top 7 stocks in the coveted Small Cap portfolio inside Zen Strategies.

Basically, we have a massive demographic tailwind for the entire medical field in the aging of the population which thus requires more healthcare. That is perfect for a company focused on bones and joints that unfortunately do fail more as we age.

This provides ample growth runway for the firm. And their excellent fundamentals do the rest of the good work to make it a stellar investment:

Top 28% AI Factor

Top 21% Momentum

Top 9% Value

Top 7% Financials

Top 6% Safety

Top 2% Growth

Top 1% Sentiment

Note that we have 7 different component grades that are designed to show the strength and weakness of every stock. 

All 7 areas score in the top 30% of all stocks. Truly no weakness to be found. 

That is about as appealing as it gets. Plus this is the type of medical device firm that combines growth with safety. That makes it appealing to own during both bullish and bearish stimes as well. 

I suspect they have the makeup of a firm that could double in price by the end of 2027 as long as they deliver on their growth expectations. Their top scores for Financials and Growth improve the odds of that happening, so let’s bag our shares now.

What To Do Next?

Bioventus (BVS) is just one of 20 stellar stocks found in my Zen Investor portfolio.

The goal is to find more stocks likely to go up 100% or more. We have bagged 4 of those so far this year:

+332% Micron (MU)

+233% SanDisk (SNDK)

+156% Flex Ltd (FLEX)

+109% Enersys (ENS)

These results help explain why the Zen Investor portfolio has generated a +40.32% year to date…yes nearly 5X better than the S&P 500. 

How is that possible?  

Perhaps it’s time to discover my unique investing process meant to unlock more 100%+ winners…and how to see my current top 20 stocks: 

Discover Zen Investor & Top 20 Stocks Now > 

p.s. my next 2 stock recommendations for the portfolio are coming soon on Wednesday August 5th. This is only for members. So click that link above to get these 2 new picks and more.  

Wishing you a world of investment success!

Steve Reitmeister…but everyone calls me Reity (pronounced “Righty”)

Editor of the Zen Investor

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.